Skip to search formSkip to main contentSkip to account menu

Stage IIIB Breast Carcinoma

Known as: breast cancer, stage IIIB, Stage IIIB Breast Cancer, Stage IIIB Breast Cancer AJCC v7 
Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0). T4: Tumor of any size with direct extension to the chest wall and/or to the skin… 
National Institutes of Health

Related topics

Related topics

9 relations
BreastEpithelial CellsEpitheliumMalignant Epithelial Cell

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Triple negative phenotype and N‐ratio are important for prognosis in patients with stage IIIB non‐inflammatory breast carcinoma
The aim is to evaluate novel prognostic factors such as triple negative (TN) phenotype and ratio between positive nodes and total… 
2008
2008
Neutropenic enterocolitis in breast cancer patient after taxane-containing chemotherapy.
Neutropenic enterocolitis or typhlitis (from the Greek typhlon, meaning caecum) is defined as a necrotizing colitis with… 
2004
2004
High dose epirubicin and cyclophosphamide in breast cancer stage IIIB
IntroductionThe aim of the study was to test the combination of high-dose 4-epiadriamycin (4-epi) with cyclophosphamide in… 
2001
2001
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report.
1999
1999
Actual 5-year survival of patients with stage IIIB breast carcinoma: phase II trial of methotrexate, vinblastine, adriamycin, cisplatin, and folinic acid.
Patients with stage IIIB breast carcinoma represent only a small proportion of women with breast cancer in western countries but… 
Highly Cited
1998
Highly Cited
1998
High-dose multimodality therapy with autologous stem-cell support for stage IIIB breast carcinoma.
PURPOSE Women with locally unresectable and inflammatory breast carcinoma (IBC) have an approximately 30% 5-year disease-free… 
1996
1996
Efficacy of up-front 5-fluorouracil-epidoxorubicin-cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients.
The prognosis of patients with stage IIIB breast carcinoma with tumour spread to the apical axillary lymph nodes has hardly… 
1990
1990
Multimodal therapy in locally advanced breast carcinoma.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License